Indefinite Delivery Contract SPE2DX22D0110

Award Date 2/3/25
Last Date to Order 12/31/31
Federal Agency
Medical Supply Chain
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued up to $999,999,999.00, runs through December 31, 2025 and serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
The federal contract IDV award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp is a single-award Indefinite Delivery Contract (IDC) valued at $999,999,999 with a period of performance through November 2026. The contract serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses a broad spectrum of critical medical commodities including specialty...
The federal contract IDV award is an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and...
This federal contract IDV award, held by Amerisourcebergen Drug Corp, is a single-award Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, which runs through December 31, 2025, aims to provide the DLA with a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The task orders and price lists indicate that Amerisourcebergen is delivering a wide...
This federal contract IDV award, with ID SPE2DX15D5002, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military...
The federal contract IDV awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp is a $999,999,999 Indefinite Delivery Contract (IDC) for the procurement of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract, which runs through November 2026, covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across...
The federal contract IDV award described is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract, valued up to $999,999,999.00 through December 31, 2025, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
The federal contract IDV awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical is a single-award Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through November 2026. This contract enables DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies from Amerisourcebergen to support military treatment programs and facilities worldwide. Amerisourcebergen, a major pharmaceutical distributor, leverages its...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $999,999,999.00, runs through December 31, 2025 and serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract...
The federal contract IDV award SPE2DX15D2218 is a $999,999,999 Indefinite Delivery Contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The task orders under this IDC cover a...
  • SPE2DX22D0110
    Indefinite Delivery Contract
  • 72
    Federal Contract Awards

The federal contract IDV award, with the ID SPE2DX22D0110, is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at up to $999,999,999, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract does not have any set-aside designations, indicating open competition. In addition to the DLA IDC, Amerisourcebergen also holds a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. The task orders under this IDC, issued between February and March 2025, demonstrate the company's ability to efficiently fulfill government contracts for essential pharmaceutical and medical commodities required by military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 6/1/25, 3:01 AM